Expert Rev Resp Med. 2012;6(3):309-319. Finally, a potential effect of tiotropium, particularly in the more recent Respimat formulation on the small airways, as was demonstrated in COPD in terms ...

The main US patent expires next year, and in the meantime BI is looking to move patients over to its newer Spiriva and Spiolto Respimat formulations to plug the gap. Anticoagulant Pradaxa’s ...

Patients with acute COPD exacerbations are seen frequently in the emergency department (ED). Acute exacerbations are associated with significant morbidity, mortality and health care expenditures ...

Inhalers for chronic obstructive pulmonary disease (COPD) are a mainstay of treatment. These medications are inhaled through your mouth so they can directly reach your lungs. If your healthcare ...